Related Experiment Video
Updated: Jun 14, 2025
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.2K
Update on Takayasu arteritis: Year in review 2024
Prakashini Mruthyunjaya1, Ramnath Misra1
1Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India.
International Journal of Rheumatic Diseases
|September 2, 2024
Summary
This review summarizes recent advances in Takayasu arteritis, a rare large vessel vasculitis impacting young women. It covers new insights into clinical features, biomarkers, imaging, and treatments for this serious condition.
Area of Science:
- Rheumatology
- Internal Medicine
- Vascular Biology
Background:
- Takayasu arteritis is a rare systemic inflammatory large vessel vasculitis.
- It predominantly affects women in their third and fourth decades.
- Aortitis and its sequelae lead to significant morbidity and mortality.
Purpose of the Study:
- To review high-impact publications from 2023 to April 2024.
- To provide updates on clinical, biomarker, imaging, and pathogenetic aspects.
- To highlight recent therapeutic advancements in Takayasu arteritis management.
Main Methods:
- Systematic review of high-impact publications.
- Focus on literature published between 2023 and April 2024.
- Synthesis of information on clinical, diagnostic, and therapeutic progress.
Main Results:
- Recent publications offer new insights into Takayasu arteritis.
- Advances include novel biomarkers and improved imaging techniques.
- Updated therapeutic strategies show promise in patient management.
Conclusions:
- Continuous research is crucial for understanding and treating Takayasu arteritis.
- The review highlights significant progress in the field.
- Personalized treatment approaches remain key for managing this vasculitis.
